Perform blood test to know the value of fats, glucose and anthropometric measurements in people who do Intermittent Fasting

Assessment of lipid profile, glycemic and anthropometric measurements in iIntermittent fasting adherents

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

REBEC

Registry ID

RBR-6vbzs7m

Enrollment

Unknown

Registered

2023-08-05

Start date

2021-01-01

Completion date

Unknown

Last updated

2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome, Obesity.

Interventions

It is a randomized controlled clinical trial where the control is a hypocaloric diet. The sample individuals will be recruited through an advertisement at a university. The sample will consist of a gr

F01.145.407.400

Eligibility

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Patients with an overweight body mass index, grade 1 obesity, or grade 2 obesity.

Exclusion criteria

Exclusion criteria: Patients who did not follow the diet correctly.

Design outcomes

Primary

Measure	Time frame
Evaluate which diet provides greater weight loss with increased lean mass and decreased fat mass.	—

Secondary

Measure	Time frame
It is expected to observe a significant decrease in the biochemical parameters of glycemia and lipid profile measured before and after the intervention.	—

Countries

Brazil

Contacts

Public Contactalessandra cristina silvério

Universidade Professor Edson Antônio Vellano

alessandrapupin72@gmail.com55(35)991058373

Outcome results

None listed

Source: REBEC (via WHO ICTRP)